Madrigal Pharmaceuticals, INC. (MDGL) SEC Filings — 2024
25 SEC filings for Madrigal Pharmaceuticals, INC. (MDGL) in 2024.
Filings
- Madrigal Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Madrigal Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Madrigal Pharmaceuticals, INC. SC 13G Filing — SC 13G · Nov 14, 2024
- Madrigal Pharmaceuticals Files 8-K on Financials — 8-K · Oct 31, 2024
- Madrigal Pharmaceuticals Files Q3 2024 10-Q Report — 10-Q · Oct 31, 2024
- Madrigal Pharmaceuticals Files 8-K on Financials — 8-K · Aug 7, 2024
- Madrigal Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 7, 2024
- Madrigal Pharmaceuticals Appoints New CMO, Elects Directors — 8-K · Jun 27, 2024
- Madrigal Pharmaceuticals Files 8-K — 8-K · May 7, 2024
- Madrigal Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
- Madrigal Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Apr 29, 2024
- Madrigal Pharma Secures $500M Credit Facility — 8-K · Apr 2, 2024
- Baker Bros. Advisors Updates Madrigal Pharma Stake — SC 13D/A · Mar 25, 2024
- Madrigal Pharmaceuticals Enters Material Definitive Agreement — 8-K · Mar 20, 2024
- Madrigal Pharma Buys Gene Therapy Assets from Arrowhead — 8-K · Mar 15, 2024
- Madrigal Pharma Files 8-K on Financial Condition — 8-K · Feb 28, 2024
- Madrigal Pharmaceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 28, 2024
- Madrigal Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Madrigal Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Madrigal Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Madrigal Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Madrigal Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- BlackRock Amends Madrigal Pharma Stake, Maintains Institutional Holding — SC 13G/A · Jan 29, 2024
- State Street Corp. Updates Passive Stake in Madrigal Pharma — SC 13G/A · Jan 22, 2024
- Madrigal Pharma Updates Business Address in 8-K Filing — 8-K · Jan 8, 2024